Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Total Liabilities

Latest as of June 2026: CN¥353.14 Million CNY ≈ $51.68 Million USD

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd total liabilities. Based on the latest financial reports, Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has total liabilities worth CN¥353.14 Million CNY (≈ $51.68 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 600671 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1993–2025)

Total liabilities of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1993 to 2025. This chart illustrates how Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Hangzhou TianMuShan Pharmaceutical Enter (600671) investment intensity to see how much of total assets are deployed in long-term investments.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Ningbo Color Master Batch Co. Ltd. SHE:301019	China	CN¥120.45 Million
Guangdong Real-Design Intelligent Technology Co. Ltd. SHE:301135	China	CN¥1.03 Billion
Suzhou Fushilai Pharmaceutical Co. Ltd. SHE:301258	China	CN¥211.52 Million
Pollard Banknote Limited TO:PBL	Canada	CA$315.29 Million
Hubei Guochuang Hi-tech Material Co Ltd SHE:002377	China	CN¥1.05 Billion
Ercros MC:ECR	Spain	€485.35 Million
Build-A-Bear Workshop Inc NYSE:BBW	USA	$175.10 Million
AnHui Annada Titanium Industry Co Ltd SHE:002136	China	CN¥902.05 Million

Liability Composition Analysis (1993–2025)

This chart breaks down Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Hangzhou TianMuShan Pharmaceutical Enter assets under control.

Liquidity & Leverage Metrics

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Total Liabilities Ratios Explained

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.84	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	4.63	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.78	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1993–2025)

The table below shows the annual total liabilities of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1993 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥348.04 Million ≈ $50.93 Million	-2.36%
2024-12-31	CN¥356.44 Million ≈ $52.16 Million	+22.77%
2023-12-31	CN¥290.34 Million ≈ $42.49 Million	-1.70%
2022-12-31	CN¥295.36 Million ≈ $43.22 Million	-12.64%
2021-12-31	CN¥338.09 Million ≈ $49.47 Million	-3.18%
2020-12-31	CN¥349.18 Million ≈ $51.10 Million	-11.29%
2019-12-31	CN¥393.60 Million ≈ $57.60 Million	-1.35%
2018-12-31	CN¥398.99 Million ≈ $58.39 Million	+12.65%
2017-12-31	CN¥354.18 Million ≈ $51.83 Million	+47.57%
2016-12-31	CN¥240.01 Million ≈ $35.12 Million	+10.29%
2015-12-31	CN¥217.63 Million ≈ $31.85 Million	+8.60%
2014-12-31	CN¥200.40 Million ≈ $29.32 Million	-12.87%
2013-12-31	CN¥230.01 Million ≈ $33.66 Million	+13.21%
2012-12-31	CN¥203.17 Million ≈ $29.73 Million	+16.09%
2011-12-31	CN¥175.00 Million ≈ $25.61 Million	+5.64%
2010-12-31	CN¥165.66 Million ≈ $24.24 Million	+17.88%
2009-12-31	CN¥140.53 Million ≈ $20.56 Million	+9.12%
2008-12-31	CN¥128.78 Million ≈ $18.85 Million	-1.81%
2007-12-31	CN¥131.16 Million ≈ $19.19 Million	+13.03%
2006-12-31	CN¥116.04 Million ≈ $16.98 Million	-12.97%
2005-12-31	CN¥133.32 Million ≈ $19.51 Million	+26.38%
2004-12-31	CN¥105.49 Million ≈ $15.44 Million	+1.56%
2003-12-31	CN¥103.88 Million ≈ $15.20 Million	-13.67%
2002-12-31	CN¥120.32 Million ≈ $17.61 Million	-23.42%
2001-12-31	CN¥157.11 Million ≈ $22.99 Million	+1.63%
2000-12-31	CN¥154.60 Million ≈ $22.62 Million	+61.58%
1999-12-31	CN¥95.68 Million ≈ $14.00 Million	+9.59%
1998-12-31	CN¥87.30 Million ≈ $12.78 Million	+23.94%
1997-12-31	CN¥70.44 Million ≈ $10.31 Million	+21.83%
1996-12-31	CN¥57.82 Million ≈ $8.46 Million	-35.04%
1995-12-31	CN¥89.00 Million ≈ $13.02 Million	-53.67%
1994-12-31	CN¥192.12 Million ≈ $28.11 Million	+610.98%
1993-12-31	CN¥27.02 Million ≈ $3.95 Million	--

About Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

SHG:600671 China Drug Manufacturers - General

Market Cap

$319.16 Million

CN¥2.18 Billion CNY

Market Cap Rank

#14200 Global

#4221 in China

Share Price

CN¥17.91

Change (1 day)

+0.62%

52-Week Range

CN¥15.94 - CN¥23.90

All Time High

CN¥37.82